Robert Allen
Technik-/Wissenschafts-/F&E-Leiter bei INVIVYD, INC.
Vermögen: - $ am 30.04.2024
Profil
Robert D.
Allen is currently the Chief Scientific Officer at Invivyd, Inc. He previously worked as the Scientific Director at Oregon Translational Research & Development Institute and as the Senior Vice President-Research & Development at Sorrento Therapeutics, Inc. From 2020 to 2023, he served as the Chief Scientific Officer at SmartPharm Therapeutics, Inc. Dr. Allen holds a doctorate degree from The Trustees of Columbia University in The City of New York, a graduate degree from Georgia Institute of Technology, and an undergraduate degree from Rhodes College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
INVIVYD, INC.
-.--% | 22.03.2024 | 0 ( -.--% ) | - $ | 30.04.2024 |
Aktive Positionen von Robert Allen
| Unternehmen | Position | Beginn |
|---|---|---|
| INVIVYD, INC. | Technik-/Wissenschafts-/F&E-Leiter | 12.04.2023 |
Ehemalige bekannte Positionen von Robert Allen
| Unternehmen | Position | Ende |
|---|---|---|
SmartPharm Therapeutics, Inc.
 SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2023 |
| Oregon Translational Research & Development Institute | Technik-/Wissenschafts-/F&E-Leiter | - |
| SORRENTO THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Robert Allen
| The Trustees of Columbia University in The City of New York | Doctorate Degree |
| Georgia Institute of Technology | Graduate Degree |
| Rhodes College | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
| Oregon Translational Research & Development Institute | |
SmartPharm Therapeutics, Inc.
SmartPharm Therapeutics, Inc. BiotechnologyHealth Technology SmartPharm Therapeutics, Inc. engages in the development of next-generation, non-viral gene therapies for the treatment of serious or rare diseases. Its pipeline include Gene MAbs for SARS-Cov-2, enzyme replacement therapy, and cell and tissue restoration. The company was founded by José Trevejo in 2017 and is headquartered in Cambridge, MA. | Health Technology |
